Clinical Trials in Austin

Showing 6541-6560 of 15,205 trials

Study to Demonstrate the Bioequivalence of Single Oral Administration of K-001 Relative to Single Oral Coadministration of Separate Tablets of K-877-ER and CSG452

NCT05722262

The goal of this clinical trial is to demonstrate the bioequivalence of single oral administration of K-001 relative to single oral co-administration of separate tablets of K-877-ER and CSG452 in healthy adult volunteers, and to characterize the food effect on the Pharmacokinetics(PK) of K-001.

Healthy

Kowa Research Institute, Inc.30 participantsStarted Feb 2023

Austin, Texas, United States

COMPLETEDNA< 1 mile

Evaluation of Updated Continuous Glucose Monitoring (CGM) Form Factor in Adults, Adolescents and Pediatrics

NCT04436822

The purpose of this study is to demonstrate the performance of the Disposable Sensor (DS5) in subjects age 2 - 80 years, for the span of 170 hours (7 days).

Type 1 Diabetes MellitusType 2 Diabetes Mellitus

Medtronic MiniMed, Inc.317 participantsStarted Jul 2020

Escondido, California, United States • Santa Barbara, California, United States • Torrance, California, United States +15 more locations

Study to Demonstrate the Bioequivalence of Single Oral Administration of K-001 Relative to Single Oral Coadministration of Separate Tablets of K-877-ER and CSG452

Evaluation of Updated Continuous Glucose Monitoring (CGM) Form Factor in Adults, Adolescents and Pediatrics

Find Trials by Condition in Austin

Oral AMXT 1501 Dicaprate in Combination With DFMO

Open-Label Study of Leuco-methylthioninium Bis(Hydromethanesulfonate) (LMTM) in Subjects With Alzheimer's Disease or Behavioral Variant Frontotemporal Dementia (bvFTD)

Comparing NUC-1031 Plus Cisplatin to Gemcitabine Plus Cisplatin in Patients With Advanced Biliary Tract Cancer

S0819: Carboplatin and Paclitaxel With or Without Bevacizumab and/or Cetuximab in Treating Patients With Stage IV or Recurrent Non-Small Cell Lung Cancer

Evaluation of the Efficacy and Safety of Lebrikizumab (LY3650150) in Moderate to Severe Atopic Dermatitis

A Study of Nivolumab or Nivolumab Plus Experimental Medication BMS-986205 With or Without Bacillus Calumette-Guerin (BCG) in BCG Unresponsive Bladder Cancer That Has Not Invaded Into the Muscle Wall of the Bladder

P2 Multi-center Study of SB204 Gel in the Treatment of Acne Vulgaris

Live Biotherapeutic Product MRx0518 and Pembrolizumab Combination Study in Solid Tumors

Single-Ascending Dose Study of JK07 in Subjects With HFpEF

Rate of Atrial Fibrillation Through 12 Months in Patients With Recent Ischemic Stroke of Presumed Known Origin

Study of Diroximel Fumarate in the Real-World Setting

Thrombosomes® in Bleeding Thrombocytopenic Patients Study

Dimethyl Fumarate (DMF) Observational Study

Evaluation of Preoperative N1539 in Total Knee Arthroplasty

An Study of Patidegib Topical Gel, 2%, for the Reduction of Disease Burden of Persistently Developing Basal Cell Carcinomas in Patients With Non-Gorlin High Frequency BCC

Proof of Concept Study of Binocular Videogames Versus Patching for Amblyopia

Diagnostic Imaging Study for the Melanoma Advanced Imaging Dermatoscope (mAID)

EMB-01 in Combination With Osimertinib in Patients With EGFR Mutant Lung Cancer